TP53 and B-cell non-Hodgkin lymphoma: AZD7762 treatment also leads to apoptosis in MYC-deregulated mouse B-cell lymphoma cells in vitro and mitigates disease progression of p53 knockout, MYC deregulated B cell lymphoma transplant mouse models in vivo (90).